Self-assembled drug delivery system based on low-molecular-weight bis-amide organogelator: synthesis, properties and in vivo evaluation

References

• Aamer KA, Heidi S, Bhatia SR, et al. (2004). Rheological studies of PLLA-PEO-PLLA triblock copolymer hydrogels. Biomaterials 25:1087–93
   PubMed Web of Science ®Google Scholar
• Anderson JM, Shive MS. (1997). Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 28:72–82
   Web of Science ®Google Scholar
• Balata G, El Nahas HM, Radwan S. (2013). Propolis organogel as a novel topical delivery system for treating wounds. Drug Deliv 21:55–61
   PubMed Web of Science ®Google Scholar
• Basak S, Nanda J, Banerjee A. (2012). A new aromatic amino acid based organogel for oil spill recovery. J Mater Chem 22:11658–64
   Web of Science ®Google Scholar
• Bastiat G, Leroux JC. (2009). Pharmaceutical organogels prepared from aromatic amino acid derivatives. J Mater Chem 19:3867–77
   PubMed Web of Science ®Google Scholar
• Bastiat G, Plourde F, Motulsky A, et al. (2010). Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer’s disease. Biomaterials 31:6031–8
   PubMed Web of Science ®Google Scholar
• Brosse N, Barth D, Jamart-Grégoire B. (2004). A family of strong low-molecular-weight organogelators based on aminoacid derivatives. Tetrahedron Lett 45:9521–4
   Web of Science ®Google Scholar
• Carter FJ, Frank TG, Davies PJ, et al. (2001). Measurements and modelling of the compliance of human and porcine organs. Med Image Anal 5:231–6
   PubMed Web of Science ®Google Scholar
• Changa JS, Huangc YB, Houa SS, et al. (2007). Formulation optimization of meloxicam sodium gel using response surface methodology. Int J Pharm 338:48–54
   PubMed Web of Science ®Google Scholar
• Chen F, Song S, Wang H, et al. (2014). Injectable chitosan thermogels for sustained and localized delivery of pingyangmycin in vascular malformations. Int J Pharm 476:232–40
   PubMed Web of Science ®Google Scholar
• Chen S, Tang G, Wu B, et al. (2015). The key effect of the self-assembly mechanism of dendritic gelators: solubility parameters, generations and terminal effects. RSC Adv 5:35282–90
   Web of Science ®Google Scholar
• Dan W, Zhao J, Liu X, et al. (2014). Parenteral thermo-sensitive organogel for schizophrenia therapy, in vitro and in vivo evaluation. Eur J Pharm Sci 60:40–8
   PubMed Web of Science ®Google Scholar
• Detroja C, Chavhan S, Sawant K. (2011). Enhanced antihypertensive activity of candesartan cilexetil nanosuspension: formulation, characterization and pharmacodynamic study. Sci Pharm 79:635–51
   PubMedGoogle Scholar
• Dudhipala N, Veerabrahma K. (2016). Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Drug Deliv 23:395–404
   PubMed Web of Science ®Google Scholar
• Florent A, Pasquale C, Quoc Nghi P, et al. (2010). Evidence of intercolumnar πnt stacking interactions in amino-acid-based low-molecular-weight organogels. Langmuir 26:16818–27
   PubMed Web of Science ®Google Scholar
• Ghasemi TF, Ganji F, Mani AR, et al. (2016). In vitro and in vivo evaluation of thermosensitive chitosan hydrogel for sustained release of insulin. Drug Deliv 23:1038–46
   PubMed Web of Science ®Google Scholar
• Giri TK, Thakur A, Alexander A, et al. (2012). Modified chitosan hydrogels as drug delivery and tissue engineering systems: present status and applications. Acta Pharm Sin 2:439–49
   Google Scholar
• Guo H, Jiao T, Shen X, et al. (2014). Binary organogels based on glutamic acid derivatives and different acids: solvent effect and molecular skeletons on self-assembly and nanostructures. Colloid Surf A Physicochem Eng Asp 447:88–96
   Web of Science ®Google Scholar
• Hanabusa K, Nakayama H, Kimura M, et al. (2000). Easy preparation and prominent gelation of new gelator based on l-lysine. Chem Lett 2000:1070–1
   Web of Science ®Google Scholar
• Jiao T, Gao F, Wang Y, et al. (2012a). Supramolecular gel and nanostructures of bolaform and trigonal cholesteryl derivatives with different aromatic spacers. Curr Nanosci 8:111–16
   Web of Science ®Google Scholar
• Jiao T, Wang Y, Gao F, et al. (2012b). Photoresponsive organogel and organized nanostructures of cholesterol imide derivatives with azobenzene substituent groups. Prog Nat Sci 22:64–70
   Web of Science ®Google Scholar
• Jiao T, Wang Y, Zhang Q, et al. (2013). Regulation of substituent groups on morphologies and self-assembly of organogels based on some azobenzene imide derivatives. Nanoscale Res Lett 8:1–8
   PubMed Web of Science ®Google Scholar
• Kempe S, Mäder K. (2012). In situ forming implants—an attractive formulation principle for parenteral depot formulations. J Control Release 161:668–679
   PubMed Web of Science ®Google Scholar
• Kuang GC, Jia XR, Teng MJ, et al. (2011). Organogels and liquid crystalline properties of amino acid-based dendrons: a systematic study on structure–property relationship. Chem Mater 24:71–80
   Web of Science ®Google Scholar
• Luboradzki R, Pakulski Z, Sartowska B. (2005). Glucofuranose derivatives as a library for designing and investigating low molecular mass organogelators. Tetrahedron 61:10122–8
   Web of Science ®Google Scholar
• Madan M, Bajaj A, Lewis S, et al. (2009). In situ forming polymeric drug delivery systems. Indian J Pharm Sci 71:242–51
   PubMed Web of Science ®Google Scholar
• Masahiro S, Tomomi N, Mariko Y, et al. (2003). l-Lysine based gemini organogelators: their organogelation properties and thermally stable organogels. Org Biomol Chem 1:4124–31
   PubMed Web of Science ®Google Scholar
• McClellan K, Kl DCN. (1998). Candesartan cilexetil. A review of its use in essential hypertension. Drugs 56:847–69
   PubMed Web of Science ®Google Scholar
• Meineke I, Feltkamp H, Högemann A, et al. (1997). Pharmacokinetics and pharmacodynamics of candesartan after administration of its pro-drug candesartan cilexetil in patients with mild to moderate essential hypertension – a population analysis. Eur J Clin Pharmacol 53:221–8
   PubMed Web of Science ®Google Scholar
• Motulsky A, Lafleur M, Couffin-Hoarau AC, et al. (2005). Characterization and biocompatibility of organogels based on l-alanine for parenteral drug delivery implants. Biomaterials 26:6242–53
   PubMed Web of Science ®Google Scholar
• Nekkanti V, Pillai R, Venkateshwarlu V, et al. (2009). Development and characterization of solid oral dosage form. Incorporating candesartan nanoparticles. Pharm Dev Technol 14:290–8
   PubMed Web of Science ®Google Scholar
• Oliver S. (2003). Eligard: leuprolide acetate in a novel sustained-release delivery system. Urology 61:25–31
   PubMed Web of Science ®Google Scholar
• Packhaeuser CB, Schnieders Joster CG, Kissel T. (2004). In situ forming parenteral drug delivery systems: an overview. Eur J Pharm Biopharm 58:445–55
   PubMed Web of Science ®Google Scholar
• Pandey M, Gattani BS, Surana S, et al. (2010). Pluronic lecithin organogel as a topical drug delivery system. Drug Deliv 17:38–47
   PubMed Web of Science ®Google Scholar
• Plourde F, Motulsky A, Couffin-Hoarau AC, et al. (2005). First report on the efficacy of l-alanine-based in situ-forming implants for the long-term parenteral delivery of drugs. J Control Release 108:433–41
   PubMed Web of Science ®Google Scholar
• Poullain-Termeau S, Crauste-Manciet S, Brossard D, et al. (2008). Effect of oil-in-water submicron emulsion surface charge on oral absorption of a poorly water-soluble drug in rats. Drug Deliv 15:503–14
   PubMed Web of Science ®Google Scholar
• Sagiri SS, Behera B, Rafanan RR, et al. (2014). Organogels as matrices for controlled drug delivery: a review on the current state. Soft Mater 12:47–72
   Web of Science ®Google Scholar
• Samai S, Dey J, Biradha K. (2011). Amino acid based low-molecular-weight tris(bis-amido) organogelators. Soft Matter 7:2121–6
   Web of Science ®Google Scholar
• Sawalha H, Margry G, Den Adel R, et al. (2013). The influence of the type of oil phase on the self-assembly process of γ-oryzanol + β-sitosterol tubules in organogel systems. Eur J Lipid Sci Technol 115:295–300
   Web of Science ®Google Scholar
• Schoenhammer K, Petersen H, Guethlein F, et al. (2009). Poly(ethyleneglycol) 500 dimethylether as novel solvent for injectable in situ forming depots. Pharm Res 26:2568–77
   PubMed Web of Science ®Google Scholar
• Shimizu M, Wang Q, Sjöquist PO, Ryden L. (1999). The angiotensin II AT1-receptor antagonist candesartan improves functional recovery and reduces the no-reflow area in reperfused ischemic rat hearts. J Cardiovasc Pharmacol 34:78–81
   PubMed Web of Science ®Google Scholar
• Supper S, Anton N, Boisclair J, et al. (2014). Chitosan/glucose 1-phosphate as new stable in situ forming depot system for controlled drug delivery. Eur J Pharm Biopharm 88:361–73
   PubMed Web of Science ®Google Scholar
• Surampalli G, Nanjwade BK, Patil PA, et al. (2014). Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation. Drug Deliv. [Epub ahead of print]. DOI: 10.3109/10717544.2014.945017
   PubMed Web of Science ®Google Scholar
• Suzuki M, Hanabusa K. (2009). l-Lysine-based low-molecular-weight gelators. Chem Soc Rev 38:967–75
   PubMed Web of Science ®Google Scholar
• Suzuki M, Nanbu M, Yumoto M, et al. (2005). Novel dumbbell-form low-molecular-weight gelators based on l-lysine: their hydrogelation and organogelation properties. New J Chem 29:1439–44
   Web of Science ®Google Scholar
• Suzuki M, Yumoto M, Shirai H, et al. (2008). A family of low-molecular-weight organogelators based on N-alpha, N-epsilon-diacyl-l-lysine: effect of alkyl chains on their organogelation behaviour. Tetrahedron 64:10395–400
   Web of Science ®Google Scholar
• Vintiloiu A, Leroux JC. (2008). Organogels and their use in drug delivery—A review. J Control Release 125:179–192
   PubMed Web of Science ®Google Scholar
• Wang C, Li Z, Wang X, et al. (2011a). Gelation mechanism and microstructure of organogels formed with l-valine dihydrazide derivatives. Colloid Surf A Physicochem Eng Asp 384:490–5
   Web of Science ®Google Scholar
• Wang K, Jia Q, Han F, et al. (2010). Self-assembled l-alanine derivative organogel as in situ drug delivery implant: characterization, biodegradability, and biocompatibility. Drug Dev Indus Pharm 36:1511–21
   PubMed Web of Science ®Google Scholar
• Wang K, Qiang J, Jing Y, et al. (2011b). A novel, simple method to simulate gelling process of injectable biodegradable in situ forming drug delivery system based on determination of electrical conductivity. Int J Pharm 404:176–9
   PubMed Web of Science ®Google Scholar
• Yang Y, Xu L, Gao Y, et al. (2012). Improved initial burst of estradiol organogel as long-term in situ drug delivery implant: formulation, in vitro and in vivo characterization. Drug Dev Indus Pharm 38:550–6
   PubMed Web of Science ®Google Scholar